Holly D. Oakley

4.9k total citations · 1 hit paper
10 papers, 3.6k citations indexed

About

Holly D. Oakley is a scholar working on Physiology, Surgery and Molecular Biology. According to data from OpenAlex, Holly D. Oakley has authored 10 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Physiology, 2 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in Holly D. Oakley's work include Alzheimer's disease research and treatments (4 papers), Computational Drug Discovery Methods (2 papers) and Circadian rhythm and melatonin (2 papers). Holly D. Oakley is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), Computational Drug Discovery Methods (2 papers) and Circadian rhythm and melatonin (2 papers). Holly D. Oakley collaborates with scholars based in United States and Austria. Holly D. Oakley's co-authors include Robert Vassar, John F. Disterhoft, Masuo Ohno, Sarah L. Cole, Erika Maus, Pei Shao, R. Stephen Berry, Linda Van Eldik, Angela Guillozet-Bongaarts and Sreemathi Logan and has published in prestigious journals such as Science, Journal of Biological Chemistry and Neuron.

In The Last Decade

Holly D. Oakley

10 papers receiving 3.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation

2006 2.5k citations Holly D. Oakley, Sarah L. Cole et al. Journal of Neuroscience profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Holly D. Oakley United States	8	2.5k	1.2k	933	924	673	10	3.6k
Guilian Xu United States	25	2.4k 1.0×	1.4k 1.2×	1.0k 1.1×	922 1.0×	650 1.0×	49	4.2k
Erika Maus United States	11	2.4k 0.9×	1.2k 1.0×	856 0.9×	934 1.0×	559 0.8×	12	3.5k
Sreemathi Logan United States	19	2.4k 0.9×	1.3k 1.1×	885 0.9×	1.0k 1.1×	502 0.7×	34	3.8k
Angela Guillozet-Bongaarts United States	16	3.0k 1.2×	1.6k 1.3×	1.3k 1.4×	1.1k 1.2×	887 1.3×	17	4.4k
Fengrong Yan United States	11	3.0k 1.2×	1.3k 1.1×	1.3k 1.4×	1.4k 1.5×	679 1.0×	11	4.1k
Sarah L. Cole United States	12	3.1k 1.2×	1.6k 1.4×	1.1k 1.1×	1.1k 1.2×	814 1.2×	14	4.5k
Jean‐Cosme Dodart United States	26	3.0k 1.2×	1.3k 1.1×	1.1k 1.2×	1.1k 1.2×	898 1.3×	38	4.1k
Thierry Bussière United States	21	3.0k 1.2×	1.6k 1.3×	922 1.0×	813 0.9×	720 1.1×	29	4.1k
Sylvain Lesné United States	27	2.0k 0.8×	1.2k 1.0×	848 0.9×	739 0.8×	540 0.8×	38	3.1k
Leigh A. Holcomb United States	16	2.5k 1.0×	1.3k 1.1×	1.0k 1.1×	623 0.7×	836 1.2×	20	3.7k

Countries citing papers authored by Holly D. Oakley

Since Specialization

Citations

This map shows the geographic impact of Holly D. Oakley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly D. Oakley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly D. Oakley more than expected).

Fields of papers citing papers by Holly D. Oakley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holly D. Oakley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly D. Oakley. The network helps show where Holly D. Oakley may publish in the future.

Co-authorship network of co-authors of Holly D. Oakley

This figure shows the co-authorship network connecting the top 25 collaborators of Holly D. Oakley. A scholar is included among the top collaborators of Holly D. Oakley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holly D. Oakley. Holly D. Oakley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Moss, Tyler J., Jordi Rodón, Holly D. Oakley, et al.. (2019). Baseline cfDNA characteristics and evolution of cfDNA profile during treatment with selective FGFR inhibitor TAS-120.. Journal of Clinical Oncology. 37(15_suppl). 3056–3056. 6 indexed citations

Bednar, Erica M., Holly D. Oakley, Charlotte C. Sun, et al.. (2017). A universal genetic testing initiative for patients with high-grade, non-mucinous epithelial ovarian cancer and the implications for cancer treatment. Gynecologic Oncology. 146(2). 399–404. 44 indexed citations

Yates, Melinda S., Kirsten M. Timms, Molly S. Daniels, et al.. (2017). Evaluation of BRCA1/2 and homologous recombination defects in ovarian cancer and impact on clinical outcomes.. Journal of Clinical Oncology. 35(15_suppl). 5511–5511. 8 indexed citations

Folick, Andrew, Holly D. Oakley, Yong Yu, et al.. (2015). Lysosomal signaling molecules regulate longevity in Caenorhabditis elegans. Science. 347(6217). 83–86. 198 indexed citations

Wang, Meng C., Holly D. Oakley, Christopher E. Carr, Jessica N. Sowa, & Gary Ruvkun. (2014). Gene Pathways That Delay Caenorhabditis elegans Reproductive Senescence. PLoS Genetics. 10(12). e1004752–e1004752. 34 indexed citations

Oakley, Holly D., Sarah L. Cole, Sreemathi Logan, et al.. (2006). Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation. Journal of Neuroscience. 26(40). 10129–10140. 2544 indexed citations breakdown →

Ohno, Masuo, Lei Chang, Holly D. Oakley, et al.. (2006). Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1. European Journal of Neuroscience. 23(1). 251–260. 244 indexed citations

Cole, Sarah L., et al.. (2005). Statins Cause Intracellular Accumulation of Amyloid Precursor Protein, β-Secretase-cleaved Fragments, and Amyloid β-Peptide via an Isoprenoid-dependent Mechanism. Journal of Biological Chemistry. 280(19). 18755–18770. 120 indexed citations

Ohno, Masuo, Evgeny A. Sametsky, Linda H. Younkin, et al.. (2004). BACE1 Deficiency Rescues Memory Deficits and Cholinergic Dysfunction in a Mouse Model of Alzheimer's Disease. Neuron. 41(1). 27–33. 428 indexed citations

10.

Cole, Sarah L., et al.. (2004). O4-02-08 A tale of two statins: the effects of lovastatin and simvastatin on APP metabolism. Neurobiology of Aging. 25. S77–S77. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact